תראקאפ 131

Pays: Israël

Langue: hébreu

Source: Ministry of Health

Ingrédients actifs:

SODIUM IODIDE (131 I)

Disponible depuis:

ELDAN ELECTRONIC INSTRUMENTS CO LTD, ISRAEL

Code ATC:

V09FX03

forme pharmaceutique:

קפסולה קשיחה

Composition:

SODIUM IODIDE (131 I) 37 - 5550 MBQ

Mode d'administration:

פומי

Type d'ordonnance:

מרשם נדרש

Fabriqué par:

GE HEALTHCARE BUCHLER GmbH & Co. KG

Groupe thérapeutique:

SODIUM IODIDE (131I)

Domaine thérapeutique:

SODIUM IODIDE (131I)

indications thérapeutiques:

Theracap 131 is a radioiodine thyroid therapy indicated for: 1. Treatment of Graves' disease, as well as focal or disseminated autonomies of the thyroid.2.Treatment of papillary and follicular thyroid carcinomas including metastases. - Whole-body-scintigraphy for monitoring papillary or follicular thyroid carcinoma. Sodium iodide 131 therapy is often combined with surgical intervention and with antithyroid medications.

Date de l'autorisation:

2015-09-30